Show
Sort by
-
- Journal Article
- A1
- open access
Nucleic acid biomarkers in Waldenstrom Macroglobulinemia and IgM-MGUS : current insights and clinical relevance
-
- Journal Article
- A1
- open access
Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL : 5 years of follow-up from the phase 3 RESONATE-2 study
-
- Journal Article
- A1
- open access
On-target pharmacodynamic activity of the PI3K inhibitor copanlisib in paired biopsies from patients with malignant lymphoma and advanced solid tumors
-
- Journal Article
- A1
- open access
Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia
-
The phase 3 DUO trial : duvelisib vs ofatumumab in relapsed and refractory CLL/SLL
-
Analysis of DNA methylation in cancer : location revisited
-
- Journal Article
- A1
- open access
Analysis of circulating microRNAs and their post-transcriptional modifications in cancer serum by on-line solid-phase extraction-capillary electrophoresis-mass spectrometry
-
- Journal Article
- A1
- open access
Digital multiplex ligation-dependent probe amplification for detection of key copy number alterations in T- and B-cell lymphoblastic leukemia
-
Long non-coding RNAs in leukemia : biology and clinical impact
-
Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies